Dr. Philomena F. McAndrew, MD

  • Beverly Hills, CA
  • Hematologist and oncologist
NPI1104822600PAC ID9234100710
Medicare services, 2024
6,746
Medicare patients, 2024
703
Part D claims, 2024
741
Publications
3
Clinical trials
5
Practice address
9090 Wilshire Blvd, Beverly Hills, CA 90211
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD

Acute Care Hospital outpatient department · Beverly Hills, California

See all 7 affiliations

Find Dr. McAndrew's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Philomena F. McAndrew is a hematologist and oncologist in Beverly Hills, California

Dr. McAndrew practices at Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California.

Dr. McAndrew's NPI, 1104822600, was assigned on June 21, 2005. Dr. McAndrew graduated from Perelman School of Medicine - Philadelphia in 1978. Dr. McAndrew holds California license G47403.

NPI and contact details
Medicare PAC ID
9234100710
NPI enumeration date
June 21, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
74
Medical school graduation
1978

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Philomena F. McAndrew practices at Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California

Dr. McAndrew's primary practice is Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD, at 9090 Wilshire Blvd, Beverly Hills, CA 90211.

  • Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD
    9090 Wilshire Blvd, Beverly Hills, CA 90211

Source: Dmand AI Affiliation Data

Dr. Philomena F. McAndrew is affiliated with 6 sites of care and 1 medical group

Dr. McAndrew's primary practice is Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California. Dr. McAndrew is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. McAndrew to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. McAndrew's employer is on file too: a hospital.

See all 7 affiliations for Dr. McAndrew

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Philomena F. McAndrew's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McAndrew practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPDAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. McAndrew practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Philomena F. McAndrew is one of 1,502 hematologists and oncologists in California

Hematology and oncology is Dr. McAndrew's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. McAndrew is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. McAndrew's licenses on file in 2 states: California and Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, CaliforniaPrimaryLicense G47403 · 1982 to 2026 · taxonomy 207RH0003X
  • Pennsylvania license1980 to 1990

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. McAndrew treats.

Hematologists and oncologists near Dr. McAndrew

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Philomena F. McAndrew billed Medicare for 6,746 services in 2024

CMS data shows 6,746 Medicare services from Dr. McAndrew across 12 procedure codes in 2024, for 703 Medicare patients. Medicare paid $192,315 for them.

Medicare services, 20246,746
Medicare patients703
Paid by Medicare$192,315
Procedure codes12

Dr. McAndrew's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 4,3002024: 4,1603%
Office and hospital visits
2023: 1,5092024: 1,4424%
Tests and treatments
2023: 5472024: 5382%
Surgery
2023: 3172024: 51763%
Other services
2023: 542024: 8965%

Where Dr. McAndrew's Medicare services took place, 2024

  • In an office6,727100%
  • In a facility190%

Dr. McAndrew compared with the California median for hematologists and oncologists, 2024

  • Dr. McAndrew
  • California median
Medicare services
6,746vs 9327.2 times
Medicare patients
703vs 2253.1 times
Part D claims
583vs 39448% above

Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.

Dr. McAndrew's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. McAndrew

Need commercial claims for Dr. McAndrew?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. McAndrew and other hematologists and oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Philomena F. McAndrew treated 703 Medicare patients in 2024, average age 75

CMS counts 703 Medicare patients who saw Dr. McAndrew in 2024. The largest group is 65 to 74, with 329 patients. 75% of them have cancer, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McAndrew's median patient age at 72, with 97% women.

Medicare patients, 2024703
Average age75
Average risk score1.30
Also on Medicaid6%

Dr. McAndrew's Medicare patients by age, 2024

Chronic conditions among Dr. McAndrew's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol75%
  3. High blood pressure57%
  4. Arthritis55%
  5. Osteoporosis50%
  6. Ischemic heart disease29%
  7. Anxiety25%
  8. Mood disorders23%

Share of Medicare patients with each condition. A patient can have several.

Dr. McAndrew's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women97%
  • Men2%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Philomena F. McAndrew wrote 741 Medicare Part D claims in 2024

In 2024, Dr. McAndrew wrote 741 Medicare Part D claims for 185 patients. 70% of them were for generic drugs. CMS names the drug for 583 of them, across 16 drugs with 11 or more claims each, at $2,276,332 in total drug cost. In 2023, CMS named 405 claims across 13 drugs.

Part D claims, 2024741
Drugs named by CMS16
Total drug cost$2.3M
Part D patients185

Dr. McAndrew's Part D claims by kind of drug, 2024

  • Generic515 claims70%
  • Brand-name226 claims30%

Dr. McAndrew's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4052024: 58344%

Drugs named by CMS: 16 in 2024, 13 in 2023.

See all prescribing by Dr. McAndrew

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Philomena F. McAndrew scored 89 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. McAndrew for performance year 2024, reported as part of a group. Dr. McAndrew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McAndrew as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. McAndrew's MIPS scores, performance year 2024

  • 89of 100Final score
  • 84.8of 100Quality
  • 99of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 73of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. McAndrew by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Philomena F. McAndrew has 3 publications on record

Dmand AI links 3 papers to Dr. McAndrew, published from 2020 to 2024. 2020 was the busiest year, with 2. Dr. McAndrew's most frequent co-authors are Heather Lynn McArthur, MD, David M.j. Hoffman, MD and Karen Anne Autio, MD.

Papers3
Years published2020 to 2024

Dr. McAndrew's most frequent co-authors

Recent publications by Dr. McAndrew

See all 3 publications and co-authors

See who Dr. McAndrew researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McAndrew works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Philomena F. McAndrew has worked on 5 clinical trials

Dmand AI links Dr. McAndrew to 5 clinical trials, 2 of them phase 1/2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms.

Clinical trials with Dr. McAndrew by phase

  1. NonePhase 1: no trials
  2. 2Phase 1/2: 2 trials
  3. 2Phase 2: 2 trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Trials with no phase (devices, behavioral studies) are left out.

Conditions in Dr. McAndrew's trials

  • Breast Neoplasms
  • Breast Diseases
  • Brain Neoplasms
  • Pathologic Complete Response
  • Triple Negative Breast Neoplasms

Investigators on the most trials with Dr. McAndrew

Recent clinical trials with Dr. McAndrew

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Philomena F. McAndrew received $1,901 in industry payments from 2016 to 2025

CMS Open Payments shows 34 general payments to Dr. McAndrew from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Stemline Therapeutics Inc. paid the most, $1,150.

General payments to Dr. McAndrew by program year, 2016 to 2025

General payments to Dr. McAndrew by kind, 2016 to 2025

$1.9Kin total
  • Consulting fees$1,15060%
  • Food and beverage$54028%
  • Education$21111%

Companies that paid Dr. McAndrew the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. McAndrew

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Philomena F. McAndrew has 5 awards and honors on record

Dmand AI lists 5 awards for Dr. McAndrew, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. McAndrew

  1. 2013
    • CMS Stage 1 EHR
    • Top Doctors:LA Area
  2. 2012
    • Top Doctors:Southern California
  3. Undated
    • Checkbook Top Doc
    • Super Doc

Source: Dmand AI Professional Profile Data

Dr. Philomena F. McAndrew graduated from Perelman School of Medicine - Philadelphia

Dr. McAndrew graduated from Perelman School of Medicine - Philadelphia in 1978.

  1. Medical schoolPerelman School of Medicine - Philadelphia
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Philomena F. McAndrew accepts plans from 7 insurance carriers

Dr. McAndrew is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • Elevance
  • Blue Cross Blue Shield of Massachusetts
  • HCSC
  • Regence Health Plans
  • CMS Medicare

Plan types Dr. McAndrew accepts, by number of carriers

  1. Medicare7
  2. PPO6
  3. POS3
  4. EPO2
  5. HMO2

Source: Dmand AI Insurance Network Data

Sources for Dr. Philomena F. McAndrew's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Philomena F. McAndrew

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Philomena F. McAndrew's NPI number?

Dr. Philomena F. McAndrew's NPI number is 1104822600. It was assigned on June 21, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Philomena F. McAndrew?

Dr. Philomena F. McAndrew is a hematologist and oncologist in Beverly Hills, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Philomena F. McAndrew practice?

Dr. McAndrew practices at 9090 Wilshire Blvd, Beverly Hills, CA 90211. Dr. McAndrew's primary practice is Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California. Dmand AI also links Dr. McAndrew to 3 hospitals and 1 group practice or clinic.

What is Dr. Philomena F. McAndrew's medical license number?

Dr. McAndrew holds California license G47403, one of the licenses on file in 2 states.

Which states has Dr. Philomena F. McAndrew been licensed in?

Dmand AI has state licenses on file for Dr. McAndrew in California (1982 to 2026) and Pennsylvania (1980 to 1990).

Which hospitals is Dr. Philomena F. McAndrew affiliated with?

Dr. McAndrew is affiliated with Ronald Reagan UCLA Medical Center. Dmand AI links Dr. McAndrew to 3 more hospitals.

What medical group is Dr. Philomena F. McAndrew part of?

Dr. McAndrew is linked to Cedars-Sinai Medical Group.

Does Dr. Philomena F. McAndrew accept Medicare?

Yes. CMS data shows Dr. McAndrew billed Medicare for 6,746 services in 2024, and Dr. McAndrew accepts Medicare assignment.

Does Dr. Philomena F. McAndrew offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. McAndrew as offering telehealth services.

What is Dr. Philomena F. McAndrew's MIPS score?

Dr. McAndrew's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Philomena F. McAndrew see?

CMS counts 703 Medicare patients who saw Dr. McAndrew in 2024, with an average age of 75.

Is Dr. Philomena F. McAndrew board certified?

Yes. Dr. McAndrew is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Philomena F. McAndrew bill to Medicare?

In 2024, Dr. McAndrew's most billed Medicare services were injected or infused drug (J9395), office visit, established patient (99214) and surgery: heart and blood vessels (36415).

Where did Dr. Philomena F. McAndrew go to medical school?

Dr. McAndrew graduated from Perelman School of Medicine - Philadelphia in 1978.

What drugs does Dr. Philomena F. McAndrew prescribe most?

In 2024 Medicare Part D data, Dr. McAndrew's most prescribed drugs by claims were Anastrozole, Exemestane and Letrozole.

Has Dr. Philomena F. McAndrew received payments from drug or device companies?

CMS Open Payments shows $1,901 in general payments to Dr. McAndrew from 8 companies from 2016 to 2025. The largest total came from Stemline Therapeutics Inc.

How long has Dr. Philomena F. McAndrew been practicing?

Dr. McAndrew graduated from medical school in 1978, 48 years ago.

Does Dr. Philomena F. McAndrew do research?

Dmand AI links 3 publications to Dr. McAndrew, published from 2020 to 2024. Dr. McAndrew has worked on 5 clinical trials.

Who does Dr. Philomena F. McAndrew publish with?

Dr. McAndrew's most frequent co-authors are Heather Lynn McArthur, MD (3 shared papers), David M.j. Hoffman, MD (2 shared papers) and Karen Anne Autio, MD (1 shared paper).

What insurance does Dr. Philomena F. McAndrew accept?

Dr. McAndrew is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)